MICHAEL F DEMANE
CIK 1174533 · Chief Executive Officer · last filed 2025-04-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$13.29M
Companies
2
Total Filings
71
Lifetime Open-Market Net
-$66.38M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NEVRO CORP (NVRO) Delisted | Director | 0 | $5.84 | $0 | -$65.58M | 65 | 2025-04-03 |
| MDT | Chief Operating Officer | 144,285 | $92.09 | $13.29M | -$803.8K | 6 | 2008-01-03 |
Recent Filings · Page 5 of 8
71 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-05-15 | NEVRO CORP (NVRO) Delisted | Exer (M) | +3,631 | $65.4K | EDGAR |
| 2017-12-22 | NEVRO CORP (NVRO) Delisted | Exer (M) | +41,572 | $149.7K | EDGAR |
| 2017-10-10 | NEVRO CORP (NVRO) Delisted | Sell (S) | −5,000 | -$467.5K | EDGAR |
| 2017-09-28 | NEVRO CORP (NVRO) Delisted | Sell (S) | −5,000 | -$457.5K | EDGAR |
| 2017-09-14 | NEVRO CORP (NVRO) Delisted | Sell (S) | −5,000 | -$447.5K | EDGAR |
| 2017-09-13 | NEVRO CORP (NVRO) Delisted | Sell (S) | −25,000 | -$2.19M | EDGAR |
| 2017-05-30 | NEVRO CORP (NVRO) Delisted | Grant (A) | +1,518 | $0 | EDGAR |
| 2017-05-03 | NEVRO CORP (NVRO) Delisted | Sell (S) | −29,800 | -$2.86M | EDGAR |
| 2017-04-05 | NEVRO CORP (NVRO) Delisted | Sell (S) | −22,200 | -$2.07M | EDGAR |
| 2017-03-30 | NEVRO CORP (NVRO) Delisted | Exer (M) | +13,620 | $59.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.